Liberty One Investment Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Liberty One Investment Management, LLC

  • $969 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 06, 2021
SELL
$61.35 - $90.47 $115,706 - $170,626
-1,886 Closed
0 $0
Q4 2020

Jan 20, 2021
SELL
$43.82 - $85.37 $438 - $853
-10 Reduced 0.53%
1,886 $145,000
Q3 2020

Nov 03, 2020
BUY
$33.21 - $51.27 $25,139 - $38,811
757 Added 66.46%
1,896 $82,000
Q2 2020

Jul 22, 2020
BUY
$26.12 - $43.27 $29,750 - $49,284
1,139 New
1,139 $49,000

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
91.1M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.96B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Liberty One Investment Management, LLC Portfolio

Follow Liberty One Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty One Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty One Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email